Get the Stockscreener App
5.48
4.36%
-0.25
Pre-market:
5.48
Clene Inc stock is traded at $5.48, with a volume of 68,828.
It is down -4.36% in the last 24 hours and up +10.48% over the past month.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
See More
Previous Close:
$5.73
Open:
$5.73
24h Volume:
68,828
Relative Volume:
0.79
Market Cap:
$64.55M
Revenue:
$200.00K
Net Income/Loss:
$-26.17M
P/E Ratio:
-2.1096
EPS:
-2.5976
Net Cash Flow:
$-18.63M
1W Performance:
-16.59%
1M Performance:
+10.48%
6M Performance:
-6.72%
1Y Performance:
+58.38%
1-Day Range:
$5.30
$5.955
1-Week Range:
$5.21
$6.74
52-Week Range:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Name
Clene Inc
Sector
Industry
Phone
801-676-9695
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
5.48 | 64.55M | 200.00K | -26.17M | -18.63M | -2.5976 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| May-02-22 | Initiated | Canaccord Genuity | Buy |
| Sep-28-21 | Initiated | Oppenheimer | Outperform |
Clene Inc Stock (CLNN) Latest News
Risk Analysis: Can Clene Inc reach resistance levels soon2026 Winners & Losers & High Accuracy Investment Signals - baoquankhu1.vn
Aug Big Picture: Will Clene Inc benefit from AI trendsGlobal Markets & Growth Focused Entry Reports - baoquankhu1.vn
Symbiosis II LLC plans resale of CLNN (NASDAQ: CLNN) — 477,000 shares - Stock Titan
If You Invested $1,000 in Clene (CLNN) - Stock Titan
Whale Trades: Will Clene Inc Equity Warrant outperform during market rallies2026 Key Lessons & Fast Momentum Entry Tips - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Hengan International Group Co (OtherHEGIF) and Clene (CLNN) - The Globe and Mail
Highs Report: What are the analyst revisions for INCYIs Clene Inc stock a good investment in YEAR - baoquankhu1.vn
Clene Secures Third-Year NIH Subaward for ALS Program - The Globe and Mail
Treasury Yields: Is Clene Inc Equity Warrant stock undervalued right nowPrice Action & Reliable Breakout Forecasts - baoquankhu1.vn
Nanotechnology Stocks To Watch TodayMarch 17th - MarketBeat
Clene Inc. Announces NIH Subaward Agreement for ALS Expanded Access Protocol – SEC Filing Details - Minichart
Clene Inc. 2025 Annual Report Highlights: Financial Performance, Risk Factors, and Future Outlook - Minichart
Clene 10-K: Revenue $0.2M, EPS $(2.65) — Net Loss $(26.17)M - TradingView
Clene (NASDAQ: CLNN) pushes CNM-Au8 toward accelerated ALS approval - Stock Titan
Clene Inc. (NASDAQ: CLNN) secures $8M Year 3 ALS grant funding - Stock Titan
Clene (CLNN) Projected to Post Earnings on Monday - MarketBeat
Q1 Earnings Estimate for Clene Issued By HC Wainwright - MarketBeat
Best Nanotechnology Stocks To ResearchMarch 15th - MarketBeat
Promising Nanotechnology Stocks Worth WatchingMarch 14th - MarketBeat
Analysts Offer Insights on Consumer Goods Companies: Clene (CLNN) and American Public Education (APEI) - The Globe and Mail
Clene Inc. (NASDAQ:CLNN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Market Fear: Is Clene Inc a play on infrastructure spendingTrade Signal Summary & Precise Buy Zone Identification - baoquankhu1.vn
Clene (NASDAQ:CLNN) Receives Buy Rating from Canaccord Genuity Group - MarketBeat
CLNN: Canaccord Genuity Reaffirms Buy Rating with $48 Target | C - GuruFocus
Clene (NASDAQ:CLNN) Issues Earnings Results - MarketBeat
Clene (CLNN) Analyst Rating Maintained at "Buy" with $23 Target - GuruFocus
Clene (NASDAQ:CLNN) Receives Buy Rating from D. Boral Capital - MarketBeat
Clene Nanomedicine "CNM-Au8" Market size expansion of Several Folds by 2034 - openPR.com
Clene Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Clene (CLNN) Reports FY25 Revenue Beat and Prepares for Key FDA Meeting - GuruFocus
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights - Investing News Network
Biopharmaceutical company Clene Inc (CLNN) recently unveiled its new financing strategy—two potential additional financings totaling over $22 millions have completed structural design. This funding plan will enable the company’s operational cash flow to la - Bitget
Clene reports full-year 2025 results: $200k revenue, $26.2M net loss - TradingView
Clene (NASDAQ: CLNN) narrows 2025 loss and readies accelerated ALS NDA filing - Stock Titan
ALS drug CNM-Au8 links biomarker declines to survival, Clene plans FDA filing - Stock Titan
Top Nanotechnology Stocks To Keep An Eye OnMarch 11th - MarketBeat
Clene Inc. (CLNN) Reports Q3 Loss, Lags Revenue Estimates - MSN
Nanotechnology Stocks To ConsiderMarch 10th - MarketBeat
Aug Selloffs: What are the analyst revisions for INCYIs Clene Inc. stock a good investment in YEARNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn
Nanotechnology Stocks To Follow NowMarch 7th - MarketBeat
Aug Movers: Should I set a stop loss on Clene IncExit Point & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Top Nanotechnology Stocks To ResearchMarch 6th - MarketBeat
Institution Moves: How do insiders feel about Clene IncQuarterly Risk Review & Capital Efficient Trading Techniques - baoquankhu1.vn
Nanotechnology Stocks To Follow TodayMarch 5th - MarketBeat
Best Nanotechnology Stocks Worth Watching – March 3rd - Defense World
CLNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Promising Nanotechnology Stocks To Follow Today – March 2nd - Defense World
Investor Mood: Is Clene Inc Equity Warrant stock undervalued right nowPortfolio Performance Report & AI Driven Stock Movement Reports - baoquankhu1.vn
Best Nanotechnology Stocks Worth WatchingMarch 3rd - MarketBeat
Top Nanotechnology Stocks To Consider – March 1st - Defense World
Promising Nanotechnology Stocks To Follow TodayMarch 2nd - MarketBeat
Clene Inc Stock (CLNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):